Breaking News Instant updates and real-time market news.

RETA

Reata Pharmaceuticals

$25.78

-0.44 (-1.68%)

07:55
02/13/18
02/13
07:55
02/13/18
07:55

Reata Pharmaceuticals to host conference call

Conference call to provide an update on the Bardoxolone rare CKD program will be held on February 13 at 8:30 am. Webcast Link

  • 13

    Feb

RETA Reata Pharmaceuticals
$25.78

-0.44 (-1.68%)

07/25/17
SBSH
07/25/17
NO CHANGE
Target $87
SBSH
Buy
Reata Pharmaceuticals price target raised to $87 from $39 at Citi
Citi analyst Yigal Nochomovitz more than doubled his price target for shares of Reata Pharmaceuticals to $87 from $39. The clinical-stage biopharmaceutical company closed yesterday up $4.37, or 14%, to $35.47. The company yesterday reported "unexpected and highly impressive" results from a Phase 2 trial testing Bardoxolone in Alport Syndrome, Nochomovitz tells investors in a research note. The data suggest "very meaningful disease reversal," the analyst argues. He believes the planned Phase 3, with data expected in 2019, should work with at least a 60% probability. Nochomovitz keeps a Buy rating on Reata shares.
08/30/17
JEFF
08/30/17
INITIATION
Target $44
JEFF
Buy
Reata Pharmaceuticals initiated with a Buy at Jefferies
Jefferies analyst Maury Raycroft started Reata Pharmaceuticals with a Buy rating and $44 price target. The company is positioned to "pursue several valuable orphan indication" markets with potential for broader use, Raycroft tells investors in a research note.
09/13/17
LEER
09/13/17
INITIATION
Target $43
LEER
Outperform
Reata Pharmaceuticals initiated with an Outperform at Leerink
Leerink analyst Joseph Schwartz started Reata Pharmaceuticals with an Outperform rating and $43 price target as he believes the company has a "strong development strategy" for its novel platform as evidenced by recent positive data in two orphan indications, and expects upcoming data in others to expand investor appreciation.
11/06/17
SBSH
11/06/17
NO CHANGE
Target $78
SBSH
Buy
Citi says time to believe in Reata's Alport syndrome data
Citi analyst Yigal Nochomovitz says it is time to believe Reata Pharmaceuticals' Alport syndrome data "are real" after the company presented positive 12-week data from the Phase 2 Cardinal trial testing bardoxolone. The shares sold off 4% Friday despite a "consistent and increasing benefit" in eGFR, a measure of kidney function, over time in a genetically-driven disease where decline in kidney function is the norm, Nochomovitz writes in a research note. Investors were hesitant to believe the data in July with only 8 patients reaching 12 weeks, but now all 30 have completed the trial and the results "are only better," the analyst contends. He keeps a Buy rating on Reata with a $78 price target. The stock closed Friday down $1.09 to $28.92.

TODAY'S FREE FLY STORIES

VRSK

Verisk Analytics

$97.04

-1.75 (-1.77%)

, CHEF

Chefs' Warehouse

$19.45

-0.75 (-3.71%)

19:41
02/20/18
02/20
19:41
02/20/18
19:41
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Verisk…

VRSK

Verisk Analytics

$97.04

-1.75 (-1.77%)

CHEF

Chefs' Warehouse

$19.45

-0.75 (-3.71%)

FLR

Fluor

$58.04

0.41 (0.71%)

RAS

RAIT Financial

$0.44

-0.031 (-6.56%)

EVBN

Evans Bancorp

$40.95

-1.55 (-3.65%)

CATM

Cardtronics

$24.69

-0.59 (-2.33%)

LC

LendingClub

$4.13

0.18 (4.56%)

BYD

Boyd Gaming

$37.60

0.26 (0.70%)

TXRH

Texas Roadhouse

$56.91

-1.07 (-1.85%)

PTLA

Portola Pharmaceuticals

$48.22

0.53 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 15

    Mar

  • 04

    May

ANW

Aegean Marine

18:47
02/20/18
02/20
18:47
02/20/18
18:47
Earnings
Aegean Marine sees Q4 EPS (69c) with items, consensus 5c »

Q4 EPS was impacted by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANW

Aegean Marine

18:44
02/20/18
02/20
18:44
02/20/18
18:44
Hot Stocks
Aegean Marine to acquire H.E.C. Europe for approximately $367M »

Aegean Marine is pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAHO

Tahoe Resources

$3.98

-0.15 (-3.63%)

18:31
02/20/18
02/20
18:31
02/20/18
18:31
Hot Stocks
Tahoe Resources announces results of PEA for la Arena II »

Tahoe Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

PCH

Potlatch

$51.95

-2.8 (-5.11%)

, DEL

Deltic Timber

$93.28

-5.17 (-5.25%)

18:22
02/20/18
02/20
18:22
02/20/18
18:22
Hot Stocks
Potlatch, Deltic Timber completer merger, change name to PotlatchDeltic »

PotlatchDeltic announced…

PCH

Potlatch

$51.95

-2.8 (-5.11%)

DEL

Deltic Timber

$93.28

-5.17 (-5.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

NGD

New Gold

$2.58

-0.05 (-1.90%)

17:59
02/20/18
02/20
17:59
02/20/18
17:59
Hot Stocks
New Gold sees FY18 consolidated gold production 525,000-595,000 ounces »

Sees FY18 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NGD

New Gold

$2.58

-0.05 (-1.90%)

17:57
02/20/18
02/20
17:57
02/20/18
17:57
Earnings
New Gold reports Q4 adjusted EPS 6c, consensus 1c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

PSA

Public Storage

$186.31

-2.44 (-1.29%)

17:48
02/20/18
02/20
17:48
02/20/18
17:48
Earnings
Public Storage reports Q4 adjusted FFO $2.75, consensus $2.72 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

HAIN

Hain Celestial

$34.68

-0.8 (-2.25%)

17:38
02/20/18
02/20
17:38
02/20/18
17:38
Hot Stocks
Breaking Hot Stocks news story on Hain Celestial »

Hain Celestial says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

ESNT

Essent Group

$46.84

-0.39 (-0.83%)

17:38
02/20/18
02/20
17:38
02/20/18
17:38
Syndicate
Breaking Syndicate news story on Essent Group »

Essent Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHCP

Ditech

$10.57

0.34 (3.32%)

17:33
02/20/18
02/20
17:33
02/20/18
17:33
Hot Stocks
Breaking Hot Stocks news story on Ditech »

Lion Point reports 26.2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIEN

Sientra

$11.21

0.08 (0.72%)

17:32
02/20/18
02/20
17:32
02/20/18
17:32
Syndicate
Sientra enters into $50M At-the-Market equity offering sales agreement »

Sientra entered into an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ENLK

EnLink Midstream Partners

$16.36

0.03 (0.18%)

17:30
02/20/18
02/20
17:30
02/20/18
17:30
Earnings
EnLink Midstream Partners reports Q4 EPS 10c, consensus 6c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 02

    May

  • 01

    Aug

  • 07

    Nov

ENLC

EnLink Midstream

$16.90

0.15 (0.90%)

17:28
02/20/18
02/20
17:28
02/20/18
17:28
Earnings
EnLink Midstream reports Q4 EPS $1.12 with items, consensus 17c »

Reports Q revenue $1.76B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 02

    May

  • 01

    Aug

HAIN

Hain Celestial

$34.68

-0.8 (-2.25%)

17:23
02/20/18
02/20
17:23
02/20/18
17:23
Hot Stocks
Hain Celestial will look at divestitures and small acquisitions »

The company is presenting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

PGH

Pengrowth Energy

$0.73

0.0072 (0.99%)

17:17
02/20/18
02/20
17:17
02/20/18
17:17
Hot Stocks
Pengrowth Energy appoints Peter Sametz as CEO »

Pengrowth Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVN

Devon Energy

$34.65

0.54 (1.58%)

17:15
02/20/18
02/20
17:15
02/20/18
17:15
Hot Stocks
Devon Energy sees accelerating growth in Delaware Basin in early FY18 »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Feb

FTK

Flotek

$5.59

0.06 (1.09%)

17:15
02/20/18
02/20
17:15
02/20/18
17:15
Earnings
Flotek reports Q4 EPS (15c), two estimate consensus 3c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 23

    Feb

  • 15

    May

RCII

Rent-A-Center

$8.93

-0.62 (-6.49%)

17:14
02/20/18
02/20
17:14
02/20/18
17:14
Hot Stocks
Rent-A-Center sees FY18 free cash flow if at least $130M »

As the Company remains in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DVN

Devon Energy

$34.65

0.53 (1.55%)

17:13
02/20/18
02/20
17:13
02/20/18
17:13
Hot Stocks
Breaking Hot Stocks news story on Devon Energy »

Devon Energy Three-year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Feb

RCII

Rent-A-Center

$8.93

-0.62 (-6.49%)

17:12
02/20/18
02/20
17:12
02/20/18
17:12
Earnings
Rent-A-Center reports Q4 EPS (41c) ex-items, consensus (7c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DVN

Devon Energy

$34.65

0.54 (1.58%)

17:12
02/20/18
02/20
17:12
02/20/18
17:12
Earnings
Devon Energy reports Q4 adjusted EPS 38c, consensus 63c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Feb

GSS

Golden Star Resources

$0.73

-0.0013 (-0.18%)

17:07
02/20/18
02/20
17:07
02/20/18
17:07
Earnings
Golden Star Resources reports Q4 EPS 4c, consensus 2c »

Reports Q revenue $81.8M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

RAS

RAIT Financial

$0.44

-0.031 (-6.56%)

17:04
02/20/18
02/20
17:04
02/20/18
17:04
Hot Stocks
RAIT Financial concludes strategic, alternative review process »

RAIT Financial Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSA

MSA Safety

$76.46

-1.14 (-1.47%)

17:02
02/20/18
02/20
17:02
02/20/18
17:02
Hot Stocks
MSA Safety expects tailwind from U.S. tax reform during FY18 »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 12

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.